National Bank of Canada FI grew its position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 21.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 42,660 shares of the biotechnology company's stock after purchasing an additional 7,560 shares during the period. National Bank of Canada FI owned approximately 0.06% of Axon Enterprise worth $25,354,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently modified their holdings of AXON. HighPoint Advisor Group LLC lifted its position in Axon Enterprise by 1.0% during the 4th quarter. HighPoint Advisor Group LLC now owns 3,897 shares of the biotechnology company's stock worth $2,316,000 after buying an additional 38 shares in the last quarter. B. Metzler seel. Sohn & Co. AG increased its position in shares of Axon Enterprise by 13.2% in the fourth quarter. B. Metzler seel. Sohn & Co. AG now owns 6,123 shares of the biotechnology company's stock valued at $3,639,000 after acquiring an additional 713 shares during the last quarter. Scalar Gauge Management LLC raised its holdings in Axon Enterprise by 44.2% during the fourth quarter. Scalar Gauge Management LLC now owns 27,400 shares of the biotechnology company's stock worth $16,284,000 after acquiring an additional 8,400 shares in the last quarter. Alliancebernstein L.P. boosted its position in Axon Enterprise by 273.8% during the fourth quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company's stock valued at $659,128,000 after purchasing an additional 812,337 shares during the last quarter. Finally, O Shaughnessy Asset Management LLC boosted its position in Axon Enterprise by 51.7% during the fourth quarter. O Shaughnessy Asset Management LLC now owns 5,447 shares of the biotechnology company's stock valued at $3,237,000 after purchasing an additional 1,856 shares during the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling
In other Axon Enterprise news, Director Jeri Williams sold 307 shares of the stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the sale, the director now directly owns 1,627 shares in the company, valued at $899,275.44. This represents a 15.87 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 6.10% of the stock is currently owned by company insiders.
Axon Enterprise Stock Performance
Shares of NASDAQ:AXON traded up $55.81 on Wednesday, reaching $559.84. 1,104,498 shares of the company's stock were exchanged, compared to its average volume of 822,355. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $715.99. The company has a fifty day moving average of $571.11 and a 200-day moving average of $558.24. The company has a market capitalization of $42.90 billion, a price-to-earnings ratio of 144.66, a PEG ratio of 5.17 and a beta of 1.13. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.
Wall Street Analyst Weigh In
A number of equities research analysts have recently issued reports on the company. TD Cowen started coverage on Axon Enterprise in a research note on Wednesday, January 8th. They set a "buy" rating and a $700.00 price objective on the stock. Craig Hallum downgraded shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday, March 10th. The Goldman Sachs Group upped their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a report on Monday, January 27th. JMP Securities reissued an "outperform" rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Finally, Barclays reaffirmed a "hold" rating on shares of Axon Enterprise in a research report on Monday, March 10th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have issued a buy rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $604.67.
Get Our Latest Report on AXON
Axon Enterprise Profile
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Further Reading
Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
